Physician profile
Farinna Willis
NPI 1861446734
$2,003.74
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.60 · 2020: $17.99 · 2021: $85.82 · 2022: $1,536 · 2023: $239 · 2024: $78.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,287.61 | 2022 | |
| Hologic Sales and Service, LLC | $224.89 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Intuitive Surgical, INC. | $146.25 | 2022-2023 | Da Vinci Surgical System |
| Shield Therapeutics INC | $116.87 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $62.04 | 2021-2023 | Slynd |
| Minerva Surgical, INC | $36.03 | 2021-2023 | |
| Abbvie INC. | $34.34 | 2019 | |
| Lupin INC. | $26.61 | 2019-2021 | |
| Applied Medical Resources Corporation | $19.22 | 2023 | |
| Mylan Pharmaceuticals INC. | $17.99 | 2020 | |
| Scynexis, INC. | $17.81 | 2021 | |
| Gynesonics, INC. | $14.08 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farinna Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.